Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Oct 2, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 28, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record2,73713 flagged findings
Reported transactions (Form 4)80since May 18, 2023 · and 10 other holdings
Corporate events (8-K)30since May 13, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-04-28share offering or dilution eventrecentOpen filing ↗“…$ 1,856,796 $ 1,931,944 LIABILITIES AND EQUITY Current liabilities: Accounts payable $ 44,176 $ 41,103 Accrued expenses 83,476 84,406…”
+1 more passage from the same document
- “…31, December 31, (In thousands) 2026 2025 2044 Royalty Financing $ 246,643 $ 246,433 2029 Convertible Notes 87,330 84,970 2033…”
- 2026-04-28capital return (buybacks/dividends)recentOpen filing ↗“…Ite m 1. Legal Proceedings See Note 12 Commitments and Contingencies to the Company’s Condensed Consolidated Financial…”
+1 more passage from the same document
- “…2025. During the three months ended March 31, 2026, the Company repurchased an additional 3,950,000 shares of Common Stock at an…”
- 2026-04-28Department of Justice inquiryrecentOpen filing ↗“…or any future tax examinations involving similar assertions, could have a material adverse effect on our financial condition,…”
+1 more passage from the same document
- “…family member). Most of these measures have already been implemented at BioReference. Following its acquisition of BioReference,…”
- 2026-04-28health plan compliance riskrecentOpen filing ↗“…a later period, reimbursement for our testing could decline. As an integral part of our billing compliance program, we periodically…”
- 2026-02-26share offering or dilution eventrecentOpen filing ↗“…Company consummated the Note Exchange Transactions related to its 2029 Convertible 144A Notes. In total, the Company exchanged…”
+1 more passage from the same document
- “…principal amount of the 2029 Convertible 144A Notes for 121,437,998 shares of Common Stock and cash payments totaling…”
- 2026-02-26capital return (buybacks/dividends)recentOpen filing ↗“…repurchased an aggregate of 34,557,844 shares of Common Stock at an average price of $1.36 per share for approximately $47.0…”
+1 more passage from the same document
- “…of record of our Common Stock. On July 18, 2024, the Company announced that its Board of Directors authorized the repurchase of…”
- 2026-02-26Department of Justice inquiryrecentOpen filing ↗“…example, to resolve a investigation and related civil action concerning alleged fee-for-service claims for payment to Medicare,…”
+1 more passage from the same document
- “…or any future tax examinations involving similar assertions, could have a material adverse effect on our financial condition,…”
- 2026-02-26health plan compliance riskrecentOpen filing ↗“…a later period, reimbursement for our testing could decline. As an integral part of our billing compliance program, we periodically…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 2,737)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 15, 268-K ↗Current report · Entered a material agreement new
- Oct 2, 268-K ↗Current report · Other events
- Aug 28, 2610-Q/A ↗Quarterly report · amendment
- Aug 28, 2610-Q/A ↗Quarterly report · amendment
- Aug 14, 268-K ↗Current report · Entered a material agreement
- Aug 7, 26SCHEDULE 13D ↗Stake with intent to influence
- Jul 27, 2610-Q ↗Quarterly report
- Jul 27, 268-K ↗Current report · Results
- Jul 1, 26SCHEDULE 13D/A ↗Stake with intent to influence · FROST PHILLIP MD ET AL · 34.1% · event on Jun 29, 26 · amendment
- Jun 18, 268-K ↗Current report · Shareholder vote results
- May 15, 26DEFA14A ↗Shareholder meeting and votes
- Apr 30, 26DEFA14A ↗Shareholder meeting and votes
- Apr 30, 26DEF 14A ↗Shareholder meeting and votes
- Apr 28, 2610-Q ↗Quarterly report
- Apr 28, 268-K ↗Current report · Results
2,737 filings on record, the oldest from Aug 14, 96.
Listing the 25 most recent filings of the 2,737 on record.
913644
- Oct 15, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Aug 14, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Mar 19, 26A senior executive left or was appointed8-K 5.02 ↗
- May 29, 25A senior executive left or was appointed8-K 5.02 ↗
- Apr 1, 25Sold unregistered shares+1 more in the same filing8-K 3.02 ↗
- Mar 28, 25Sold unregistered shares+1 more in the same filing8-K 3.02 ↗
- Mar 11, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Sep 16, 24Completed an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
- Jul 29, 24A senior executive left or was appointed8-K 5.02 ↗
- Jul 17, 24Took on a new financial obligation+3 more in the same filing8-K 2.03 ↗
- Mar 28, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Feb 9, 24A senior executive left or was appointed8-K 5.02 ↗
8 older filings not shown · The record reaches back to Sep 10, 04.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jun 13, 16Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Oct 19, 12Listing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
- Dec 29, 11Listing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
- Oct 13, 11Listing notice (8-K 3.01)+4 more in the same filing8-K 3.01 ↗
- Sep 14, 11Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Nov 9, 10Past accounts declared unreliable and being restated+1 more in the same filing8-K 4.02 ↗
- May 7, 10Listing notice (8-K 3.01)8-K 3.01 ↗
- Oct 14, 04Listing notice (8-K 3.01)8-K 3.01 ↗
- Sep 10, 04Listing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
The full record holds 9 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- FROST PHILLIP MD ET AL34.1%Jun 29, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- HSIAO JANE PH D4.5%Apr 2, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Rubric Capital Management LP6.0%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Mar 20, 26Buy$11KJOHN A PAGANELLI↗
- Nov 21, 25Buy$133KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 21, 25Buy$5KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 21, 25Buy$118KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 21, 25Buy$255KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 21, 25Buy$257KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 20, 25Buy$157KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 20, 25Buy$62KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 20, 25Buy$282KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 20, 25Buy$216KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 20, 25Buy$33KPHILLIP MD ET AL FROSTCEO & Chairman↗
- Nov 20, 25Buy$2KPHILLIP MD ET AL FROSTCEO & Chairman↗
There are 24 more transactions in this stretch.
Stock compensation, tax and giftsshow the 4 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 194 transactions and goes back to Feb 10, 23.
Its sector and its market
Opko Health Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Opko Health Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Opko Health Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 2,737 documents on file, from Aug 14, 1996 to Oct 15, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.